Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
about
Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferationRole of TIM-3 in ovarian cancer.Laminins affect T cell trafficking and allograft fate.Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.Tim-3 and its role in regulating anti-tumor immunity.Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory.Regulation of T cell responses by the receptor molecule Tim-3.Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.Tim-3 expression defines regulatory T cells in human tumors.Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cellsMechanisms of immune tolerance to allergens: role of IL-10 and TregsActivation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid CancerTIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.An obligate cell-intrinsic function for CD28 in TregsTIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.Glycobiology of cell death: when glycans and lectins govern cell fate.Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.New insights into T-cell cosignaling in allograft rejection and survival.Emerging immune checkpoints for cancer therapy.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.T Cell Cosignaling Molecules in Transplantation.Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.Induction, control, and plasticity of Treg cells: the immune regulatory network revised?Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.Tim-3, Lag-3, and TIGIT.Immune regulation by Tim-3.Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.Common Features of Regulatory T Cell Specialization During Th1 Responses.Next generation immune-checkpoints for cancer therapy.Novel Effector Phenotype of Tim-3 Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients
P2860
Q24297200-E6412DC1-3434-4FE6-94F3-3BD250323567Q30235023-F11A47ED-4E40-45C1-AC59-E82BDFBEB3BCQ30577194-CC8BB0CA-D167-46A9-9484-CCE12087A91CQ33650505-7FEFBC58-47A2-4DEC-A288-74E7CA480670Q33909020-A3B26D7F-D0BA-4176-86D0-F25FF8D8EBE9Q33944179-E9902A97-38BB-4DAA-BC83-036687E4E269Q34017074-50662EF8-2B1E-43C7-8653-3781F057D16EQ34195216-03F7C137-DA5C-4FEC-9EAF-F21A61B25800Q34634058-9A9E2B45-C374-4C1E-96A7-48C122C406BEQ34718313-3448B111-88F7-4350-A410-610BF9D18E34Q34769749-E0543304-53CA-415E-B8CD-174B2BACE3FEQ35140130-8008C1B4-4BCE-430D-BAD7-842922609495Q35637207-8505A9A8-1717-4B88-8B25-E1A457730560Q35688947-8370761A-9D6D-4DAC-B16E-CBB1C0D3C049Q35954111-3EE0EF5C-B906-4876-A44C-86CB5FB3F90EQ36509345-E20BCD60-1F78-45BE-ABC9-C5EFCD575A9EQ36580415-7F028635-8ED3-44EE-B92B-7FA2D6CD6E9DQ36845835-309F62FA-71CF-4F4B-817B-37918A2FFC56Q36917904-79500FEC-6584-4257-BEDD-BB02471B0783Q36994801-86BE439C-23C4-46C0-85EE-F5EDE22AB52EQ37178510-EFA2DE9C-912A-4F4A-A78F-43524ED98BC6Q37729313-95677DB4-E8F8-42DF-876B-929C183D9FABQ38309285-CCAFD2FF-3EF9-47F0-9CD4-8FF334CD9D85Q38584979-53BE3AE6-8EBE-45E2-96BD-F037FA7C52D3Q38837469-8C4BAD07-DB6A-4995-98EB-5CF361FB258FQ38837473-C5FFAFE6-B3D5-4568-BDD9-586D3265AD1FQ38897638-CA97398B-7C62-4D5D-BEBA-D128724C2307Q39161011-707BF360-1A51-48AE-A26B-0DD591908B39Q40891481-995C726B-9C49-4B0A-839E-D806402204C7Q41049928-623D93E1-0F2E-4D18-8F0A-A7355FB91459Q41894013-65A24EB9-8F94-41B0-A188-AAFCFE815AA6Q42154142-CFD9C657-9341-4178-AF2F-FC4AD806E6A5Q44661076-6F6AD55D-B017-4ABD-9FFD-D2BBAF160D86Q46520709-AB3CCE5F-BB7F-47B5-966E-01B1C9C8A1F9Q50125564-DFB1CCF2-ABD2-4BA0-B863-9A2A31F520B2Q52348457-BDE3F836-B17E-42E1-B292-71262EE71F06Q55285607-9E66B87B-EF94-4EF5-AF50-2E6468CFE867Q55315496-BBA5D89D-970D-4E71-B7E0-DE5A7E23AD18Q55383705-F42F48F9-E1B6-4AC8-AC2B-237E719DEFE4Q56888845-0EF2BB34-E234-48BB-86EE-70D6E5A0B238
P2860
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@ast
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@en
type
label
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@ast
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@en
prefLabel
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@ast
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@en
P2093
P2860
P356
P1476
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
@en
P2093
Laurence A Turka
Rafael Larocca
Shipra Gupta
Terry B Strom
Vijay K Kuchroo
P2860
P304
P356
10.1172/JCI45138
P407
P577
2012-06-11T00:00:00Z